Andrew Pearson

Andrew Pearson is a Postdoctoral Scientist at The Roskamp Institute since May 2022, focusing on the molecular targets of drugs derived from thieno[2,3-b]pyridine by utilizing copper-catalyzed azide-alkyne cycloaddition and various bioinformatics techniques. Previously, Andrew conducted M.Sc thesis research at Keele University in 2017 and served as an Administrative Assistant at East Lancashire Hospitals NHS Trust in 2016, where responsibilities included supporting engineers and clinical scientists in medical equipment maintenance and ensuring proper logistics for hospital supplies. Andrew holds a Master of Science in Cell and Tissue Engineering from Keele University and a Bachelor of Science in Biological and Biomedical Sciences from the University of Chester.